Announcements
- Coloplast A/S - Announcement no. 02/2023 - Interim Financial Report, H1 2022/23
- Coloplast A/S - Selskabsmeddelelse nr. 02/2023 - Regnskabsmeddelelse, 1. halvår 2022/23
- Studie viser signifikant forbedring af blæretømning med Coloplasts Luja™ sammenlignet med konkurrentkateter
- Study shows significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter
- Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
- Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier
- Coloplast A/S - Allocation of Share Options
- Coloplast A/S - Allokering af aktieoptioner
- Coloplast lancerer nyt kateter til mænd udviklet til at mindske risikoen for urinvejsinfektioner
- Coloplast launches male catheter designed to reduce the risk of urinary tract infections
More ▼
Key statistics
On Friday, Coloplast A/S (0QBO:LSE) closed at 876.10, -11.67% below its 52-week high of 991.80, set on May 08, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 876.10 |
---|---|
High | -- |
Low | -- |
Bid | 857.60 |
Offer | 894.60 |
Previous close | 872.50 |
Average volume | 34.36k |
---|---|
Shares outstanding | 198.00m |
Free float | 108.81m |
P/E (TTM) | 38.75 |
Market cap | 173.21bn DKK |
EPS (TTM) | 22.58 DKK |
Annual div (ADY) | 20.00 DKK |
---|---|
Annual div yield (ADY) | 2.29% |
Div ex-date | May 15 2023 |
Div pay-date | May 17 2023 |
Data delayed at least 20 minutes, as of Jun 02 2023 17:42 BST.
More ▼